330 related articles for article (PubMed ID: 18267276)
1. SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease.
Booij J; Knol RJ
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S425-8. PubMed ID: 18267276
[TBL] [Abstract][Full Text] [Related]
2. The role of SPECT imaging of the dopaminergic system in translational research on Parkinson's disease.
Suwijn SR; de Bruin K; de Bie RM; Booij J
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S184-6. PubMed ID: 24262177
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.
de Natale ER; Niccolini F; Wilson H; Politis M
Int Rev Neurobiol; 2018; 141():131-172. PubMed ID: 30314595
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders.
Akdemir ÜÖ; Bora Tokçaer A; Atay LÖ
Turk J Med Sci; 2021 Apr; 51(2):400-410. PubMed ID: 33237660
[TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter (DAT) imaging in Parkinson's disease and related disorders.
Brücke T; Brücke C
J Neural Transm (Vienna); 2022 Jun; 129(5-6):581-594. PubMed ID: 34910248
[TBL] [Abstract][Full Text] [Related]
7. SPECT Molecular Imaging in Familial Parkinson's Disease.
Varrone A; Pellecchia MT
Int Rev Neurobiol; 2018; 142():225-260. PubMed ID: 30409254
[TBL] [Abstract][Full Text] [Related]
8. Disease-related and drug-induced changes in dopamine transporter expression might undermine the reliability of imaging studies of disease progression in Parkinson's disease.
Winogrodzka A; Booij J; Wolters ECh
Parkinsonism Relat Disord; 2005 Dec; 11(8):475-84. PubMed ID: 16257254
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
Nicastro N; Nencha U; Burkhard PR; Garibotto V
J Neurochem; 2023 Feb; 164(3):346-363. PubMed ID: 34935143
[TBL] [Abstract][Full Text] [Related]
10. Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease.
Alvarez-Fischer D; Blessmann G; Trosowski C; Béhé M; Schurrat T; Hartmann A; Behr TM; Oertel WH; Höglinger GU; Höffken H
Neuroimage; 2007 Oct; 38(1):5-12. PubMed ID: 17716921
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging.
Berendse HW; Ponsen MM
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S26-30. PubMed ID: 20083001
[TBL] [Abstract][Full Text] [Related]
13. Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
Arena JE; Stoessl AJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S47-51. PubMed ID: 26439947
[TBL] [Abstract][Full Text] [Related]
14. Assessing dopaminergic function in Parkinson's disease: levodopa kinetic-dynamic modeling and SPECT.
Contin M; Martinelli P; Riva R; Dondi M; Fanti S; Pettinato C; Scaglione C; Albani F; Baruzzi A
J Neurol; 2003 Dec; 250(12):1475-81. PubMed ID: 14673582
[TBL] [Abstract][Full Text] [Related]
15. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
[TBL] [Abstract][Full Text] [Related]
16. Role of DAT-SPECT in the diagnostic work up of parkinsonism.
Scherfler C; Schwarz J; Antonini A; Grosset D; Valldeoriola F; Marek K; Oertel W; Tolosa E; Lees AJ; Poewe W
Mov Disord; 2007 Jul; 22(9):1229-38. PubMed ID: 17486648
[TBL] [Abstract][Full Text] [Related]
17. High-accuracy Automated Diagnosis of Parkinson's Disease.
Ozsahin I; Sekeroglu B; Pwavodi PC; Mok GSP
Curr Med Imaging; 2020; 16(6):688-694. PubMed ID: 32723240
[TBL] [Abstract][Full Text] [Related]
18. Pre- and postsynaptic dopamine SPECT in the early phase of idiopathic parkinsonism: a population-based study.
Mo SJ; Linder J; Forsgren L; Larsson A; Johansson L; Riklund K
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2154-64. PubMed ID: 20593284
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study.
Berger HJ; Cools AR; Horstink MW; Oyen WJ; Verhoeven EW; van der Werf SP
Neuropsychologia; 2004; 42(8):1071-8. PubMed ID: 15093146
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease and dopamine transporter neuroimaging: a critical review.
Shih MC; Hoexter MQ; Andrade LA; Bressan RA
Sao Paulo Med J; 2006 May; 124(3):168-75. PubMed ID: 17119698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
